Avian Mycoplasmosis in Poultry: Diagnosis and Control Strategies

Introduction

Avian mycoplasmosis represents a group of economically significant respiratory and synovial infections in poultry caused by bacteria of the genus Mycoplasma, primarily Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS). These cell wall-deficient bacteria belong to the class Mollicutes and are characterized by their small genome size (approximately 800-1000 kbp), reduced metabolic capacity, and obligate parasitic lifestyle. MG is the primary etiological agent of chronic respiratory disease (CRD) in chickens and infectious sinusitis in turkeys, while MS causes infectious synovitis and respiratory disease in both species. The economic impact of these infections stems from reduced egg production, increased feed conversion ratios, carcass condemnation at slaughter, and mortality from secondary bacterial infections. This article provides a detailed examination of the pathogenesis, clinical presentation, diagnostic methodologies, and control strategies for avian mycoplasmosis, with emphasis on recent advances in molecular detection and vaccine development.

Pathogenesis and Host-Pathogen Interactions

Mycoplasma gallisepticum

MG colonizes the mucosal epithelium of the upper respiratory tract, including the trachea, sinuses, and air sacs. The organism adheres to host cells via specialized attachment organelles, including the GapA and CrmA cytadhesins, which bind to sialic acid residues on host epithelial cells. Following attachment, MG induces ciliostasis, loss of ciliated epithelial cells, and mucosal inflammation. The bacterium produces hydrogen peroxide and superoxide radicals as byproducts of its metabolism, contributing to oxidative damage of host tissues. MG also modulates host immune responses by inducing apoptosis in macrophages and lymphocytes, thereby facilitating persistent infection.

Co-infection with other respiratory pathogens, such as Escherichia coli, Avian influenza virus, or Infectious bronchitis virus, significantly exacerbates disease severity. A cross-sectional study in commercial free-range layers demonstrated complex pathogen interactions in upper respiratory tract infections, highlighting that polymicrobial infections involving MG and other agents result in more severe clinical outcomes compared to single-pathogen infections [1].

Mycoplasma synoviae

MS exhibits a broader tissue tropism than MG, colonizing both the respiratory tract and the synovial membranes of joints and tendon sheaths. The bacterium produces a hemagglutinin protein (MshA1-MshA2) that mediates attachment to host cells and erythrocytes. MS infection can remain subclinical for extended periods, with clinical disease often triggered by environmental stressors or concurrent infections. A study on Cryptosporidium baileyi and MS co-infection demonstrated that co-infection enhances MS colonization and aggravates tissue damage in chickens, suggesting synergistic pathogenic mechanisms between these pathogens [2].

The concept of host-pathogen coevolution and its influence on behavioral tolerance to infection has been explored in avian systems. Populations with a longer history of pathogen coevolution may exhibit higher behavioral tolerance, which has implications for disease transmission dynamics and control strategies in poultry flocks [3].

Clinical Signs and Pathological Findings

Chickens

MG infection in chickens typically presents as chronic respiratory disease characterized by rales, coughing, nasal discharge, and conjunctivitis. In layer flocks, egg production may decline by 10-20 percent, and eggshell quality deteriorates with increased incidence of shell thinning and misshapen eggs. Airsacculitis is a common postmortem finding, often complicated by secondary E. coli infection leading to fibrinous airsacculitis and pericarditis.

MS infection in chickens can manifest as either respiratory disease or infectious synovitis. The synovial form presents with lameness, swollen joints (particularly the hock and wing joints), breast blisters, and sternal bursitis. Affected birds show reluctance to move, reduced feed intake, and stunted growth. A case report of avian influenza co-infection and multifactorial diseases in a broiler chicken farm highlighted the role of MS as a contributing factor in complex disease presentations [4].

Turkeys

In turkeys, MG causes infectious sinusitis, characterized by swelling of the infraorbital sinuses, nasal discharge, and respiratory distress. The disease can result in significant mortality, particularly in young poults. MS infection in turkeys primarily causes synovitis, with lameness and joint swelling being the predominant clinical signs.

Diagnostic Approaches

Serological Diagnostics

Serological testing remains a cornerstone of avian mycoplasmosis surveillance programs. The most commonly employed serological methods include the rapid serum agglutination (RSA) test, hemagglutination inhibition (HI) test, and enzyme-linked immunosorbent assay (ELISA). The RSA test is a simple, rapid screening tool that detects antibodies against MG and MS using stained antigen preparations. However, the RSA test has limited specificity due to cross-reactions with other Mycoplasma species. The HI test provides greater specificity and is often used as a confirmatory test following positive RSA results. Commercial ELISA kits offer high throughput and quantitative results, making them suitable for large-scale surveillance programs.

Serological evidence of MG and MS exposure has been documented in trafficked parrots and macaws in Colombia, indicating that non-poultry avian species may serve as reservoirs for these pathogens and contribute to their spread [5].

Molecular Diagnostics

Molecular diagnostic methods have revolutionized the detection and differentiation of MG and MS, offering superior sensitivity and specificity compared to serological and culture-based methods.

Conventional and Real-Time PCR

Polymerase Chain Reaction (PCR) assays targeting species-specific genes, such as the mgc2 gene for MG and the vlhA gene for MS, are widely used for direct detection of these pathogens in clinical samples. A multiplex TaqMan real-time PCR assay has been developed for differential identification of wild-type and vaccine strains of MG [6]. This assay enables simultaneous detection and differentiation of field isolates from live vaccine strains, which is critical for monitoring vaccine efficacy and distinguishing vaccine reactions from true infections.

Colorimetric Loop-Mediated Isothermal Amplification (LAMP)

Loop-mediated isothermal amplification (LAMP) has emerged as a field-deployable alternative to PCR for detection of MG. A high-throughput colorimetric LAMP assay with intelligent algorithm-assisted analysis has been developed for MG detection [7]. This assay utilizes a pH-sensitive dye that changes color upon amplification, allowing visual interpretation without specialized equipment. Another study described a field-ready colorimetric LAMP assay for MG detection using rapid DNA extraction methods, making it suitable for point-of-care testing in poultry farms [8].

Molecular Typing

Molecular typing methods, including multilocus sequence typing (MLST) and variable lipoprotein hemagglutinin (vlhA) gene sequencing, are used for epidemiological investigations of MS outbreaks. A 14-year study in Italy applied molecular typing to characterize MS isolates from industrial and backyard poultry, revealing the genetic diversity and transmission patterns of MS in different production systems [9].

Culture and Isolation

Culture of MG and MS requires specialized media, such as Frey's medium or modified Hayflick's medium, supplemented with serum and yeast extract. The organisms grow slowly, forming typical "fried egg" colonies on solid media after 3-10 days of incubation at 37 degrees Celsius in a 5-10 percent carbon dioxide atmosphere. Culture is labor-intensive and has lower sensitivity compared to molecular methods, but it remains important for antimicrobial susceptibility testing and vaccine strain characterization.

Diagnostic Algorithm

The following Mermaid diagram illustrates a diagnostic algorithm for avian mycoplasmosis in poultry flocks.

flowchart TD
    A[Clinical suspicion: respiratory signs, synovitis, egg drop], > B[Sample collection: tracheal swabs, joint fluid, serum]
    B, > C{Initial screening}
    C, > D[Serology: RSA or ELISA]
    C, > E[Direct detection: PCR or LAMP]
    D, > F{Positive?}
    E, > G{Positive?}
    F, >|Yes| H[Confirmatory HI test]
    F, >|No| I[Consider other etiologies]
    G, >|Yes| J[Species identification: MG vs MS]
    G, >|No| K[Consider culture or repeat sampling]
    H, > L{Confirmed?}
    L, >|Yes| J
    L, >|No| I
    J, > M[Further characterization]
    M, > N[Multiplex TaqMan PCR for vaccine/wild-type differentiation]
    M, > O[Molecular typing: MLST or vlhA sequencing]
    M, > P[Antimicrobial susceptibility testing]
    N, > Q[Informed control strategy]
    O, > Q
    P, > Q

Control Strategies

Vaccination

Vaccination is a key component of avian mycoplasmosis control programs. Both live attenuated and inactivated vaccines are available for MG, and recombinant vector vaccines have been developed for both MG and MS.

Live Attenuated Vaccines

The F-strain live vaccine is the most commonly used MG vaccine in layer pullets. It provides protection against respiratory disease and egg production losses but can retain residual virulence and may cause disease in turkeys. A study evaluating vaccination programs in layer pullets compared recombinant fowlpox-MG vaccine with commercially available F-strain live vaccines [10]. The recombinant vaccine demonstrated comparable efficacy to the live vaccine while offering improved safety profile and reduced risk of vaccine-induced disease.

Recombinant Vector Vaccines

Recombinant fowl adenovirus vectors have been explored for MS vaccination. A study demonstrated protection of chickens against MS infection by vaccination with a recombinant fowl adenovirus 4 expressing the P50 protein [11]. This approach offers the advantage of DIVA (Differentiating Infected from Vaccinated Animals) capability, as vaccinated animals can be serologically distinguished from naturally infected animals.

Antimicrobial Therapy

Antimicrobial treatment is used for therapeutic and metaphylactic purposes in affected flocks. The most commonly used antimicrobials include tylosin, tilmicosin, tiamulin, and enrofloxacin. However, antimicrobial resistance is an increasing concern, and susceptibility testing is recommended to guide treatment decisions. A pharmacokinetic/pharmacodynamic study of a novel pleuromutilin derivative APTM against MG demonstrated favorable PK/PD parameters, suggesting potential for clinical application [12].

Biosecurity and Management

Biosecurity measures are essential for preventing introduction and spread of MG and MS in poultry flocks. Key measures include:

• Acquisition of replacement stock from certified mycoplasma-free sources
• Implementation of all-in/all-out production systems
• Strict visitor and equipment sanitation protocols
• Rodent and wild bird control programs
• Monitoring of sentinel birds

Regional pathogen surveillance in free-ranging wild turkeys has demonstrated that wild birds can serve as reservoirs for MG and MS, highlighting the importance of biosecurity measures to prevent contact between domestic poultry and wild bird populations [13].

Alternative Therapeutic Approaches

Research into alternative therapeutic agents for MG infection has identified several promising compounds. Scutellaria baicalensis extracellular vesicles have been shown to attenuate MG-induced inflammation via TRPC1-STIM1/ORAI1 channel inhibition [14]. Luteolin, a natural flavonoid, has demonstrated multifaceted anti-MG activity by targeting TatD nuclease and the MAPK pathway [15]. These alternative approaches may provide additional tools for managing mycoplasma infections in the context of increasing antimicrobial resistance.

Conclusion

Avian mycoplasmosis remains a significant challenge for the global poultry industry. The development of advanced molecular diagnostic tools, including colorimetric LAMP assays and multiplex real-time PCR methods, has improved the speed and accuracy of diagnosis. Vaccination strategies have evolved from traditional live attenuated vaccines to recombinant vector vaccines offering improved safety and DIVA capability. Integrated control programs combining vaccination, antimicrobial therapy, biosecurity, and surveillance are essential for effective management of MG and MS infections in poultry flocks.

References

[1] Rodrigo CH, Kulappu Arachchige SN, Bushell RN, et al. Complex pathogen interactions in upper respiratory tract infections in commercial free-range layers: A cross-sectional study. Vet Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42190304/

[2] Zhang Y, Li Y, Wang Z, et al. Cryptosporidium baileyi and Mycoplasma synoviae co-infection enhances M. synoviae colonization and aggravates tissue damage in chickens. Front Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42158394/

[3] Adelman JS, Henschen AE, Tillman FE Jr, et al. The devil you know: a longer history of pathogen coevolution predicts higher behavioural tolerance of infection among host populations. Biol Lett. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42124517/

[4] Hartady T, Sugandi SD, Viqih M. A Case of Avian Influenza Co-Infection and Multifactorial Diseases in a Broiler Chicken Farm in Majalengka, West Java, Indonesia. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42076736/

[5] Marín-Villa J, Alzate-Vargas JF, Ramírez TG, et al. Serological evidence and risk factors of Mycoplasma gallisepticum and Mycoplasma synoviae exposure in trafficked parrots and macaws in Colombia. Open Vet J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41630737/

[6] Xin J, Zhang J, Liang S, et al. A multiplex TaqMan real-time PCR assay for differential identification of wild-type and vaccine strains of Mycoplasma gallisepticum. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41702344/

[7] Jing W, Cai Q, Liang Y, et al. High-throughput colorimetric LAMP detection of Mycoplasma gallisepticum with intelligent algorithm-assisted analysis. Anal Methods. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41891257/

[8] Mayne R, Pant SD, Huang J, et al. A field-ready colourimetric LAMP assay for detection of Mycoplasma gallisepticum using rapid DNA extraction. Res Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41785617/

[9] Stefani E, Morales-Arce AY, Nai G, et al. Molecular typing of Mycoplasma synoviae in industrial and backyard poultry: a 14-year study in Italy. Appl Environ Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41817199/

[10] Hashish A, Chaves M, Osemeke O, et al. Evaluation of Vaccination Programs in Layer Pullets Using Recombinant Fowl-Pox Mycoplasma gallisepticum Vaccine in Comparison to Commercially Available F-Strain Live Vaccines. Avian Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41973009/

[11] Liu Y, Li W, Li G, et al. Protection of chickens against M. synoviae infection by vaccination with a recombinant fowl adenovirus 4-P50. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41887300/

[12] Yang W, Ding H, Ma X, et al. Pharmacokinetic/pharmacodynamic relationship of a novel pleuromutilin derivative APTM against Mycoplasma gallisepticum. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41650639/

[13] Edge AC, Moorman CE, Pacifici K, et al. Regional Pathogen Surveillance of Free-Ranging Wild Turkeys (Meleagris gallopavo) in North Carolina, USA. J Wildl Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41667058/

[14] Xu F, Bao L, Yao Y, et al. Mechanism of Scutellaria baicalensis extracellular vesicles in attenuating Mycoplasma gallisepticum-induced inflammation via TRPC1 - STIM1/ORAI1 channel inhibition. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41905072/

[15] Liu W, Wang S, Hu J, et al. Targeting TatD nuclease and the MAPK Pathway: Luteolin multifaceted approach against Mycoplasma gallisepticum infection. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41548475/